Dr. Martens is going to go public on the London Stock Exchange at the end of this year or early in 2020, according to a report in Il Sole 24 Ore, the Italian business daily. Permira, the investment fund that bought the brand for £300 million (€347.0m-$385.8m) in 2013, is reportedly seeking a valuation of £1 billion (€1.2bn-$1.3bn), or about 12 times its Ebitda for the past year, which reached £85 million (€98.3m-$109.3m). Earlier reports indicated that it wanted to sell Dr. Martens for £1.2 billion. In its latest fiscal year, Dr. Martens posted revenues of £454.4 million (€525.6m-$584.4m), up by 30 percent. Permira had indicated earlier this year that it was considering cashing out of its investment as an alternative to a public offering.